Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.
Yousaf-Khan U, et al. Among authors: lammers jw.
Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30.
Thorax. 2017.
PMID: 27364640
Clinical Trial.